GSK Press Releases - EIN Presswire - Press Release Distribution Service

Published on December 17, 2013 - 09:47 GMT

GSK announces changes to its global sales and marketing practices to further ensure patient interests come first

Company to roll out new sales force compensation programme, removing individual sales targets Begins process to end direct payments to healthcare professionals for speaking engagements or attendance at medical conferences by start of 2016 Issued: Tuesday …

Distribution channels: Companies

Published on December 16, 2013 - 09:10 GMT

GSK initiates voluntary open offer to increase stake in its pharmaceuticals subsidiary in India

16 December 2013 GlaxoSmithKline (GSK) (LSE: GSK) today announced a Voluntary Open Offer (the “Offer”) to increase its stake in its publicly-listed pharmaceuticals subsidiary in India (GlaxoSmithKline Pharmaceuticals Limited, the “Company”) from 50.7% to …

Distribution channels: Companies

Published on December 11, 2013 - 00:38 GMT

GSK announces £200 million investment in UK advanced manufacturing and science

Wednesday 11 December, 2013, 00:01 GMT GSK today announced a series of investments totalling approximately £200 millionthat will support the delivery of the company’s pipeline of new medicines and create a centre for pharmaceutical manufacturing innovation …

Distribution channels: Companies

Published on December 6, 2013 - 14:21 GMT

GSK and Theravance announce positive results from pivotal phase III study for fluticasone furoate/vilanterol in asthma

- Study meets primary efficacy endpoint Issued: Friday 6 December 2013, London UK and South San Francisco, CA, USA GlaxoSmithKline (GSK) and Theravance, Inc. (NASDAQ: THRX) today announced positive results from a phase III efficacy and safety study of …

Distribution channels: Companies

Published on December 6, 2013 - 11:00 GMT

Update regarding 2010 Nature Medicine study

05 December 2013 A GSK research paper published in 2010* that was found earlier this year to contain incorrect data has now been retracted by Nature Medicine. The publication, on which several Shanghai-based GSK scientists were named authors, detailed …

Distribution channels: Companies

Published on December 5, 2013 - 13:44 GMT

Synflorix™ receives European marketing authorisation for additional pneumonia indication

GlaxoSmithKline (GSK) today announced that the European Commission (EC) has granted marketing authorisation for an additional indication for Synflorix™ for the immunisation against pneumonia caused by Streptococcus pneumoniae in children from six weeks up …

Distribution channels: Companies

Published on December 5, 2013 - 13:44 GMT

GSK launches global consortium with six renowned cancer research centres

Issued: 5 December 2013, London UK and Philadelphia, PA Oncology Clinical and Translational Consortium (OCTC) to include centres in US, Canada, France, the Netherlands and Spain Projects to focus on oncology clinical trials including combination therapies, …

Distribution channels: Companies

Published on November 28, 2013 - 12:34 GMT

Regulatory Update - GSK receives positive CHMP opinion for Cervarix™ two-dose schedule

Today, GlaxoSmithKline plc (GSK) announced that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) is recommending marketing authorisation for a two-dose schedule in 9-14 year old girls for its cervical cancer vaccine …

Distribution channels: Companies

Published on November 25, 2013 - 23:09 GMT

GSK Responds to FDA Decision on Avandia (rosiglitazone)

Issued: 25 November 2013, London UK GSK plc [LSE/NYSE: GSK] announced today that the U.S. Food and Drug Administration (FDA) has eased restrictions on patient access to Avandia (rosiglitazone), following an FDA Advisory Committee review in June 2013. GSK …

Distribution channels: Companies

Published on November 25, 2013 - 14:42 GMT

H5N1 vaccine approved by the U.S. FDA as pandemic influenza preparedness measure

GlaxoSmithKline plc (LSE/NYSE: GSK) announced today that the U.S. Food and Drug Administration (FDA) has approved its pandemic Influenza A (H5N1) Virus Monovalent Vaccine, Adjuvanted (also referred to as Q-Pan H5N1 influenza vaccine) for the immunisation …

Distribution channels: Companies

Published on November 22, 2013 - 14:50 GMT

Tivicay® (dolutegravir) receives positive CHMP opinion in Europe for the treatment of HIV

London, UK, 21 November 2013 ViiV Healthcare today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending marketing authorisation for Tivicay® (dolutegravir …

Distribution channels: Companies

Published on November 20, 2013 - 21:53 GMT

GSK and Amicus Therapeutics announce revised Fabry agreement

Issued: Wednesday 20 November 2013, London, UK Cranbury, New Jersey - Amicus acquires full rights to global drug development, regulatory and commercial activities for migalastat HCI - GSK retains interest through additional equity investment in Amicus and …

Distribution channels: Companies

Published on November 19, 2013 - 17:27 GMT

Information in respect of an offering of shares of Aspen Pharmacare Holdings Limited

The information to which this gatepost gives access is exclusively intended for persons who are not residents of the United States and who are not physically present in the United States. This information does not constitute an offer, or an invitation to …

Distribution channels: Companies

Published on November 18, 2013 - 15:37 GMT

RELVAR® ELLIPTA® receives European marketing authorisation for the treatment of asthma and COPD

Issued: Monday 18 November 2013, London, UK South San Francisco, CA – LSE announcement GlaxoSmithKline plc (GSK) and Theravance, Inc. (NASDAQ: THRX) announced today that the European Commission has granted marketing authorisation for RELVAR® ELLIPTA®, …

Distribution channels: Companies

Published on November 14, 2013 - 10:17 GMT

Five inspirational organisations from Malawi, Bangladesh, Mali, Kenya, and Colombia recognised by GSK and Save the Children

-Winners of $1 million award to support lifesaving innovations announced -First initiative to be delivered in partnership between GSK and Save the Children that aims to save a million children’s lives. Issued: Thursday 14 November 2013, London UK A simple …

Distribution channels: Companies

Published on November 12, 2013 - 07:37 GMT

GSK announces top-line results from pivotal Phase III study of darapladib in chronic coronary heart disease

Issued: Tuesday 12 November 2013, London UK – LSE Announcement GlaxoSmithKline (LSE:GSK) today announced top-line results from the Phase III STABILITY trial (STabilisation of Atherosclerotic plaque By Initiation of darapLadIb TherapY), evaluating the …

Distribution channels: Companies

Published on November 6, 2013 - 11:15 GMT

GSK names inaugural winners in unique competition for academic drug hunters

Issued: Wednesday 06 November 2013, Philadelphia, PA - Eight academic scientists in North America receive chance for a collaborative partnership with pharma focused on the discovery of new medicines - “Discovery Fast Track” competition draws 142 proposals …

Distribution channels: Companies

Published on November 5, 2013 - 13:47 GMT

GSK announces new apprentice and graduate engineering opportunities in the UK during Tomorrow’s Engineers Week

Issued: Tuesday 5 November 2013, London UK GSK today announced the recruitment of 140 new apprentices over the next two years in the UK – of which a third will be in engineering. This represents a 27% increase in the company’s annual intake of apprentices …

Distribution channels: Companies

Published on November 4, 2013 - 17:36 GMT

GSK announces data to support Cervarix® two-dose schedule for the prevention of cervical cancer in 9-14 year old girls

Issued: Monday 4 November 2013, London UK GlaxoSmithKline (GSK) plc today announced the results of a Phase III study of its HPV vaccine, Cervarix [Human papillomavirus (types 16 and 18) vaccine, recombinant], which showed that two doses of the vaccine in …

Distribution channels: Companies

Published on October 29, 2013 - 12:34 GMT

New partnership between GSK and the Bill & Melinda Gates Foundation to accelerate research into vaccines for global health needs

- Vaccine Discovery Partnership (VxDP) announcement at the Foundation’s Grand Challenges Meeting in Rio de Janeiro signals commitment to find solutions to the challenges facing the developing world Issued: Tuesday 29 October 2013, London UK; Rio, Brazil; …

Distribution channels: Companies